Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
MBCQ dilates coronary arteries via specific inhibition of cGMP-PDE
3)33-19(27)10-13-30-16-25(26
Imexon (BM 06002) in combination with DTIC results in an increase in the peak plasma imexon level in non-tumor-bearing mice
InChi: InChI=1S/C19H21N5O3/c1-22-10-11-23(2)18(13-22)21-17-9-8-15(24(26)27)12-16(17)19(25)20-14-6-4-3-5-7-14/h3-9
minipigs 6 and monkey 6 %) following intravenous administration (rats 0
R1663 SIAB MBCQ dilates coronary arteries viaR1663 is a factor Xa inhibitor with anticoagulant activity. R1663 does not affect bleeding time. The pharmacodynamic effects (such as inhibition of thrombin generation) and plasma concentrations of R1663 are dose dependent. R1663 prolongs clotting time in a concentration dependent manner and inhibits the peak height of thrombin generation and endogenous thrombin potential. Product information CAS Number: 865451 66 7 Molecular Weight: 519. 90 Formula:
US$ 127.50
US$ 28.95
US$ 34.00
US$ 32.00
US$ 845.00
US$ 289.50
US$ 499.50
US$ 21.00
US$ 194.50
US$ 150.00
US$ 62.00
US$ 49.00
US$ 524.50
US$ 44.00